| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |